Abstract:1377 Objectives Small interfering RNA (siRNA) tumor imaging and therapies administered by intravenous injection require a highly efficient delivery system to perform the function of gene silencing. The overall purpose of this study was to develop and characterize a novel integrin αvβ3-specific delivery vector for improving transfection of siRNA in malignant tumors in vitro. Methods For specific siRNA delivery to tumor cells, we adopted a cyclic Arg-Gly-Asp (RGD) peptide as a promising molecule for recognition of tumor tissues expressing integrin ανβ3. To enable siRNA binding, a chimaeric peptide was synthesized by adding nonamer arginine residues (9R) at the carboxy terminus of cyclic-RGD dimer, designated as c(RGD)2-9R. To verify the combination of c(RGD)2-9R with siRNA, electrophoresis on 2% agarose gels was performed. The stability of c(RGD)2-9R/siRNA in different conditions were confirmed by electrophoresis. The efficiency of c(RGD)2-9R peptides transferring siRNA was evaluated in vitro by the methods of flow cytometry and confocal microscopy. All data were analyzed with the statistical software SPSS17.0, and a value of P less than 0.05 was considered to be statistically significant. Results The peptide of c(RGD)2-9R was able to bind siRNA in a dose-dependent manner. An optimal 10:1 molar ratio of c(RGD)2-9R to siRNA was confirmed. The complex of c(RGD)2-9R/siRNA remained stable and complete at room temperature and in fresh 37oC human serum, even after 72h. The results of flow cytometry showed that the average siRNA transfection efficiencies of c(RGD)2-9R and liposome were 61.0%±13.4% and 91.5%±1.84%, respectively, which were all much higher than that of FAM-siRNA alone (8.08%±6.45%) (P Conclusions The chimaeric peptide of c(RGD)2-9R is considered to be an effective siRNA delivery vector in vitro, and a hopeful application in vivo needs further examination.

In Vitro Investigation of RGD-modified Stabilized Cationic Liposomes As Non-Viral Vehicle for Sirna Delivery

Redox-Responsive and Electrically Neutral PLGA Nanoparticles for Sirna Delivery in Human Cervical Carcinoma Cells

Integrin Receptor-Mediated Strategy for Tumor Targeting Delivery of siRNA and Doxorubicin

A Polycation Coated Liposome As Efficient Sirna Carrier to Overcome Multidrug Resistance

Enhancement of ovarian cancer chemotherapy by delivery of multidrug-resistance gene small interfering RNA using tumor targeting Salmonella.

Distinctive Polymer Micelle Designed for Sirna Delivery and Reversal of MDR1 Gene-Dependent Multidrug Resistance.

Enhanced Gene Delivery Efficiency of Cationic Liposomes Coated with PEGylated Hyaluronic Acid for Anti P-glycoprotein Sirna: A Potential Candidate for Overcoming Multi-Drug Resistance

In Vitro Studies of Phospholipid-Modified PAMAM-siMDR1 Complexes for the Reversal of Multidrug Resistance in Human Breast Cancer Cells.

Delivery of Sirna by MRI-visible Nanovehicles to Overcome Drug Resistance in MCF-7/ADR Human Breast Cancer Cells.

An RGD-modified MRI-visible Polymeric Vector for Targeted Sirna Delivery to Hepatocellular Carcinoma in Nude Mice.

Overcoming multidrug resistance by co-delivering of MDR1 targeting siRNA and doxorubicin using EphA10-mediated pH-sensitive lipoplexes：In vitro and in vivo evaluation.

Construction and Characterization of Crgd-Modified 9-Arginine Peptide As A Novel Vector for Targeted Sirna Delivery

In Vitro And In Vivo Inhibition Of Mrp Gene Expression And Reversal Of Multidrug Resistance By Sirna

Redox-responsive Mesoporous Silica Nanoparticles: a Physiologically Sensitive Codelivery Vehicle for Sirna and Doxorubicin.

Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery

doxorubicin-prodrug nanoparticles as siRNA drug delivery system for cancer treatment : in vitro and in vivo †

Cytological Study in Vitro on Co-delivery of Sirna and Paclitaxel Within Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Tumors

Systemic Administration of Sirna Via Crgd-Containing Peptide

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery

Tumor-Targeted In Vivo Gene Silencing Via Systemic Delivery Of Crgd-Conjugated Sirna

Self-assembly Nanomicelles Based on Cationic Mpeg-Pla-b-polyarginine(r15) Triblock Copolymer for Sirna Delivery.